Quarterly report · Q2
2112.TEDINET S100PGCP
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥25.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥274m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥454m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥389m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥389m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥233m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥233m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥25.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥26.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.7bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥14.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥15.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.0bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥104m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥210m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥172m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥711m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥482m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥948m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥5.1 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.14 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.61 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.55 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 41.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥67m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥8m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥577m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥925m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥891m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥34m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥238m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥582m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥851m |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥66m |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥58m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥8m |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥50m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥50m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥586m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥939m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥910m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥28m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥264m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥11.3bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥11.3bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥14m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥745m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥12.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥50m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00361 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 21120 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)塩水港精糖株式会社 | |
| Filer name in english | FilingDateInstant | Ensuiko Sugar Refining Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(スタンダード市場) | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式 単元株式数は100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)三菱商事株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内２丁目３－１ | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２丁目１１－３ | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社みずほ銀行 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町１丁目５－５ | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)三菱ＵＦＪ信託銀行株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目４－５ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |